دورية أكاديمية
Percutaneous mitral valve repair for mitral regurgitation in high-risk patients: results of the EVEREST II study
| العنوان: | Percutaneous mitral valve repair for mitral regurgitation in high-risk patients: results of the EVEREST II study |
|---|---|
| المؤلفون: | Glower, Donald D, Kar, Saibal, Trento, Alfredo, Lim, D Scott, Bajwa, Tanvir, MD, Quesada, Ramon, Whitlow, Patrick L, Rinaldi, Michael J, Grayburn, Paul, Mack, Michael J, Mauri, Laura, McCarthy, Patrick M, Feldman, Ted |
| المصدر: | Cardiovascular Surgery |
| بيانات النشر: | Advocate Aurora Health Institutional Repository |
| سنة النشر: | 2014 |
| المجموعة: | Aurora Health Care Digital Repository |
| مصطلحات موضوعية: | high surgical risk, mitral valve insufficiency, Cardiology |
| الوصف: | BACKGROUND: The EVEREST II (Endovascular Valve Edge-to-Edge REpair STudy) High-Risk registry and REALISM Continued Access Study High-Risk Arm are prospective registries of patients who received the MitraClip device (Abbott Vascular, Santa Clara, California) for mitral regurgitation (MR) in the United States. OBJECTIVES: The purpose of this study was to report 12-month outcomes in high-risk patients treated with the percutaneous mitral valve edge-to-edge repair. METHODS: Patients with grades 3 to 4+ MR and a surgical mortality risk of ≥12%, based on the Society of Thoracic Surgeons risk calculator or the estimate of a surgeon coinvestigator following pre-specified protocol criteria, were enrolled. RESULTS: In the studies, 327 of 351 patients completed 12 months of follow-up. Patients were elderly (76 ± 11 years of age), with 70% having functional MR and 60% having prior cardiac surgery. The mitral valve device reduced MR to ≤2+ in 86% of patients at discharge (n = 325; p < 0.0001). Major adverse events at 30 days included death in 4.8%, myocardial infarction in 1.1%, and stroke in 2.6%. At 12 months, MR was ≤2+ in 84% of patients (n = 225; p < 0.0001). From baseline to 12 months, left ventricular (LV) end-diastolic volume improved from 161 ± 56 ml to 143 ± 53 ml (n = 203; p < 0.0001) and LV end-systolic volume improved from 87 ± 47 ml to 79 ± 44 ml (n = 202; p < 0.0001). New York Heart Association functional class improved from 82% in class III/IV at baseline to 83% in class I/II at 12 months (n = 234; p < 0.0001). The 36-item Short Form Health Survey physical and mental quality-of-life scores improved from baseline to 12 months (n = 191; p < 0.0001). Annual hospitalization rate for heart failure fell from 0.79% pre-procedure to 0.41% post-procedure (n = 338; p < 0.0001). Kaplan-Meier survival estimate at 12 months was 77.2%. CONCLUSIONS: The percutaneous mitral valve device significantly reduced MR, improved clinical symptoms, and decreased LV dimensions at 12 months in this ... |
| نوع الوثيقة: | text |
| اللغة: | unknown |
| العلاقة: | https://institutionalrepository.aah.org/cardiosurg/2Test |
| DOI: | 10.1016/j.jacc.2013.12.062 |
| الإتاحة: | https://doi.org/10.1016/j.jacc.2013.12.062Test https://institutionalrepository.aah.org/cardiosurg/2Test |
| رقم الانضمام: | edsbas.530559C1 |
| قاعدة البيانات: | BASE |
| ResultId |
1 |
|---|---|
| Header |
edsbas BASE edsbas.530559C1 785 3 Academic Journal academicJournal 784.518249511719 |
| PLink |
https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsbas&AN=edsbas.530559C1&custid=s6537998&authtype=sso |
| FullText |
Array
(
[Availability] => 0
)
Array ( [0] => Array ( [Url] => https://doi.org/10.1016/j.jacc.2013.12.062# [Name] => EDS - BASE [Category] => fullText [Text] => View record in BASE [MouseOverText] => View record in BASE ) ) |
| Items |
Array
(
[Name] => Title
[Label] => Title
[Group] => Ti
[Data] => Percutaneous mitral valve repair for mitral regurgitation in high-risk patients: results of the EVEREST II study
)
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Glower%2C+Donald+D%22">Glower, Donald D</searchLink><br /><searchLink fieldCode="AR" term="%22Kar%2C+Saibal%22">Kar, Saibal</searchLink><br /><searchLink fieldCode="AR" term="%22Trento%2C+Alfredo%22">Trento, Alfredo</searchLink><br /><searchLink fieldCode="AR" term="%22Lim%2C+D+Scott%22">Lim, D Scott</searchLink><br /><searchLink fieldCode="AR" term="%22Bajwa%2C+Tanvir%2C+MD%22">Bajwa, Tanvir, MD</searchLink><br /><searchLink fieldCode="AR" term="%22Quesada%2C+Ramon%22">Quesada, Ramon</searchLink><br /><searchLink fieldCode="AR" term="%22Whitlow%2C+Patrick+L%22">Whitlow, Patrick L</searchLink><br /><searchLink fieldCode="AR" term="%22Rinaldi%2C+Michael+J%22">Rinaldi, Michael J</searchLink><br /><searchLink fieldCode="AR" term="%22Grayburn%2C+Paul%22">Grayburn, Paul</searchLink><br /><searchLink fieldCode="AR" term="%22Mack%2C+Michael+J%22">Mack, Michael J</searchLink><br /><searchLink fieldCode="AR" term="%22Mauri%2C+Laura%22">Mauri, Laura</searchLink><br /><searchLink fieldCode="AR" term="%22McCarthy%2C+Patrick+M%22">McCarthy, Patrick M</searchLink><br /><searchLink fieldCode="AR" term="%22Feldman%2C+Ted%22">Feldman, Ted</searchLink> ) Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => Cardiovascular Surgery ) Array ( [Name] => Publisher [Label] => Publisher Information [Group] => PubInfo [Data] => Advocate Aurora Health Institutional Repository ) Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2014 ) Array ( [Name] => Subset [Label] => Collection [Group] => HoldingsInfo [Data] => Aurora Health Care Digital Repository ) Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22high+surgical+risk%22">high surgical risk</searchLink><br /><searchLink fieldCode="DE" term="%22mitral+valve+insufficiency%22">mitral valve insufficiency</searchLink><br /><searchLink fieldCode="DE" term="%22Cardiology%22">Cardiology</searchLink> ) Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => BACKGROUND: The EVEREST II (Endovascular Valve Edge-to-Edge REpair STudy) High-Risk registry and REALISM Continued Access Study High-Risk Arm are prospective registries of patients who received the MitraClip device (Abbott Vascular, Santa Clara, California) for mitral regurgitation (MR) in the United States. OBJECTIVES: The purpose of this study was to report 12-month outcomes in high-risk patients treated with the percutaneous mitral valve edge-to-edge repair. METHODS: Patients with grades 3 to 4+ MR and a surgical mortality risk of ≥12%, based on the Society of Thoracic Surgeons risk calculator or the estimate of a surgeon coinvestigator following pre-specified protocol criteria, were enrolled. RESULTS: In the studies, 327 of 351 patients completed 12 months of follow-up. Patients were elderly (76 ± 11 years of age), with 70% having functional MR and 60% having prior cardiac surgery. The mitral valve device reduced MR to ≤2+ in 86% of patients at discharge (n = 325; p < 0.0001). Major adverse events at 30 days included death in 4.8%, myocardial infarction in 1.1%, and stroke in 2.6%. At 12 months, MR was ≤2+ in 84% of patients (n = 225; p < 0.0001). From baseline to 12 months, left ventricular (LV) end-diastolic volume improved from 161 ± 56 ml to 143 ± 53 ml (n = 203; p < 0.0001) and LV end-systolic volume improved from 87 ± 47 ml to 79 ± 44 ml (n = 202; p < 0.0001). New York Heart Association functional class improved from 82% in class III/IV at baseline to 83% in class I/II at 12 months (n = 234; p < 0.0001). The 36-item Short Form Health Survey physical and mental quality-of-life scores improved from baseline to 12 months (n = 191; p < 0.0001). Annual hospitalization rate for heart failure fell from 0.79% pre-procedure to 0.41% post-procedure (n = 338; p < 0.0001). Kaplan-Meier survival estimate at 12 months was 77.2%. CONCLUSIONS: The percutaneous mitral valve device significantly reduced MR, improved clinical symptoms, and decreased LV dimensions at 12 months in this ... ) Array ( [Name] => TypeDocument [Label] => Document Type [Group] => TypDoc [Data] => text ) Array ( [Name] => Language [Label] => Language [Group] => Lang [Data] => unknown ) Array ( [Name] => NoteTitleSource [Label] => Relation [Group] => SrcInfo [Data] => https://institutionalrepository.aah.org/cardiosurg/2 ) Array ( [Name] => DOI [Label] => DOI [Group] => ID [Data] => 10.1016/j.jacc.2013.12.062 ) Array ( [Name] => URL [Label] => Availability [Group] => URL [Data] => https://doi.org/10.1016/j.jacc.2013.12.062<br />https://institutionalrepository.aah.org/cardiosurg/2 ) Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsbas.530559C1 ) |
| RecordInfo |
Array
(
[BibEntity] => Array
(
[Identifiers] => Array
(
[0] => Array
(
[Type] => doi
[Value] => 10.1016/j.jacc.2013.12.062
)
)
[Languages] => Array
(
[0] => Array
(
[Text] => unknown
)
)
[Subjects] => Array
(
[0] => Array
(
[SubjectFull] => high surgical risk
[Type] => general
)
[1] => Array
(
[SubjectFull] => mitral valve insufficiency
[Type] => general
)
[2] => Array
(
[SubjectFull] => Cardiology
[Type] => general
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Percutaneous mitral valve repair for mitral regurgitation in high-risk patients: results of the EVEREST II study
[Type] => main
)
)
)
[BibRelationships] => Array
(
[HasContributorRelationships] => Array
(
[0] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Glower, Donald D
)
)
)
[1] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Kar, Saibal
)
)
)
[2] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Trento, Alfredo
)
)
)
[3] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Lim, D Scott
)
)
)
[4] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Bajwa, Tanvir, MD
)
)
)
[5] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Quesada, Ramon
)
)
)
[6] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Whitlow, Patrick L
)
)
)
[7] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Rinaldi, Michael J
)
)
)
[8] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Grayburn, Paul
)
)
)
[9] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Mack, Michael J
)
)
)
[10] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Mauri, Laura
)
)
)
[11] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => McCarthy, Patrick M
)
)
)
[12] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Feldman, Ted
)
)
)
)
[IsPartOfRelationships] => Array
(
[0] => Array
(
[BibEntity] => Array
(
[Dates] => Array
(
[0] => Array
(
[D] => 01
[M] => 01
[Type] => published
[Y] => 2014
)
)
[Identifiers] => Array
(
[0] => Array
(
[Type] => issn-locals
[Value] => edsbas
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Cardiovascular Surgery
[Type] => main
)
)
)
)
)
)
)
|
| IllustrationInfo |